Literature DB >> 3923952

The lupus anticoagulant, pulmonary thromboembolism, and fatal pulmonary hypertension.

B M Rothschild.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3923952      PMCID: PMC1001650          DOI: 10.1136/ard.44.5.357-a

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  9 in total

1.  Arterial thrombosis, intrauterine death and "lupus" antiocoagulant: detection of immunoglobulin interfering with prostacyclin formation.

Authors:  L O Carreras; G Defreyn; S J Machin; J Vermylen; R Deman; B Spitz; A Van Assche
Journal:  Lancet       Date:  1981-01-31       Impact factor: 79.321

2.  Serine esterase inhibition and immune modulation.

Authors:  B M Rothschild
Journal:  Semin Arthritis Rheum       Date:  1984-02       Impact factor: 5.532

Review 3.  Antithrombins: clinical aspects, chemical and biologic properties.

Authors:  J A Penner; M J Hunter
Journal:  Prog Clin Biol Res       Date:  1976

4.  The role of antithrombin III in clinical management of pulmonary embolization.

Authors:  B M Rothschild
Journal:  Am J Med       Date:  1983-04       Impact factor: 4.965

5.  Antithrombin-III transfusion in disseminated intravascular coagulation.

Authors:  P M Blatt; G C White; J C Goldsmith; H R Roberts
Journal:  Lancet       Date:  1978-06-03       Impact factor: 79.321

6.  The lupus anticoagulant, pulmonary thromboembolism, and fatal pulmonary hypertension.

Authors:  N E Anderson; M R Ali
Journal:  Ann Rheum Dis       Date:  1984-10       Impact factor: 19.103

7.  Severe homozygous protein C deficiency.

Authors:  R H Sills; R A Marlar; R R Montgomery; G N Deshpande; J R Humbert
Journal:  J Pediatr       Date:  1984-09       Impact factor: 4.406

8.  Reduced prostacyclin activity in systemic lupus erythematosus.

Authors:  B A McVerry; S J Machin; H Parry; A H Goldstone
Journal:  Ann Rheum Dis       Date:  1980-10       Impact factor: 19.103

9.  Inherited protein C deficiency and coumarin-responsive chronic relapsing purpura fulminans in a newborn infant.

Authors:  H E Branson; J Katz; R Marble; J H Griffin
Journal:  Lancet       Date:  1983-11-19       Impact factor: 79.321

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.